Vivani Medical (NASDAQ:VANI – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.
Vivani Medical Trading Up 0.9 %
NASDAQ VANI opened at $1.10 on Tuesday. The business’s 50-day moving average price is $1.16 and its two-hundred day moving average price is $1.22. Vivani Medical has a 12 month low of $1.03 and a 12 month high of $2.22. The firm has a market capitalization of $65.16 million, a PE ratio of -2.44 and a beta of 3.20.
Analyst Ratings Changes
Separately, HC Wainwright restated a “buy” rating and set a $4.00 target price on shares of Vivani Medical in a research report on Thursday, March 13th.
About Vivani Medical
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Further Reading
- Five stocks we like better than Vivani Medical
- How to Short a Stock in 5 Easy Steps
- Can TikTok Stock Picks Really Make You Rich?
- What is a Dividend King?
- The “Quality” Rotation: Back to Basics Investing
- 3 Fintech Stocks With Good 2021 Prospects
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
